Stem Cell Standardisation deal inked between new players Sistemic and leaders Roslin Cells
London, 10th May 2011: Sistemic Ltd and Roslin Cells Ltd today signed a Memorandum of Understanding to promote the development of new technologies for the standardisation of the manufacture of stem cells for their use in cell therapy and drug development screening. Both parties believe that only through the development of stem cell standardisation can the full potential of this major opportunity be unlocked.
Sistemic is delighted to announce this agreement with Roslin and believe that the ground-breaking research has the potential to greatly advance the use of stem cells for cell therapies and research. Jim Reid, Sistemic’s CEO commented "Standardisation is a key step in the broader exploitation of any technology. We have been using our SistemQC™ microRNA based service with clients working in these fields to help them gain a greater molecular understanding of their stem cell systems and have built a comprehensive understanding of the issues this sector currently faces. We have been looking both at early characterisation during the R&D phase, right through to generating microRNA fingerprints which can be used in the release of products from manufacture. We have been finding that there is a general consensus within the stem cell community that the currently available tools and technologies are not truly fit for purpose. Broader utility will be driven by better standardisation. As more and more of these developments enter clinical testing and subsequent market launch the role for new tools and technologies to really understand these systems is essential. We believe that our SistemQC™, microRNA approach will play a key part in delivering these enhanced tools and in collaboration with Roslin set the standard for stem cell characterisation and quality."
Roslin Cells, world leaders in the isolation of new clinical grade, undifferentiated stem cells for use in both research and therapy are ideally placed to assess the developing utility of technologies coming from the collaboration. Their current stem cells benefit from being highly characterised and thoroughly tested in Roslin’s cGMP compliant facility and they are recognised as one of the world’s leading centres in this field. Roslin, aim to be at the forefront of stem cell characterisation and as such the collaboration with Sistemic is a natural fit to develop the highest standards for stem cell production, from development, through scale up and the release of high quality cells following manufacture. Aidan Courtney, CEO of Roslin commented that "The characterisation of both primary tissue and of cells in culture is fundamental to our operation. It underpins our ability to produce the highest possible quality of cells for use in cell therapies and as research tools. Data from cell characterisation tests are an essential element of what we provide to our customers and collaborators. This collaboration with Sistemic will enable us to improve our production processes and deliver more extensive and valuable data to those using our cells."
About Roslin Cells
Roslin Cells Ltd was established as an independent company by Roslin Institute in 2006 with the aim of providing ethically sourced, pluripotent human cells manufactured to the highest quality available according to Good Manufacturing Practice (GMP standards). This level of quality is critical to their intended use in therapeutic applications. The Company now also assists academic and commercial researcher organisations to translate fundamental research into GMP compliant processes which can be used in the production of cell therapies. In October 2010 the Company announced its Cell
Therapy Partner Program through which it helps the development of new cell therapies. Roslin Cells is headquartered near Edinburgh, Scotland, and is a not for profit organisation. Further information can be found at www.roslincells.com.
About Sistemic Ltd
Sistemic’s primary business is focussed on providing innovative microRNA-based problem-solving services and kit-based products to areas of unmet need within Pharmaceutical, Biotechnology and the Cell Therapy research, development and manufacture markets. MicroRNAs are seen as the master controllers of a cell and as such Sistemic believe that they are providing instructive information on effects on a whole cell or organism rather than an isolated pathway. This system approach means that the data produced is more indicative of the biology and more diagnostic of actual effect. Their extensive suite of tools for the Cell Therapy community includes SistemQC™ which is used to characterise cells including stem cells (Cell Identity, Purity, Potency, and Safety) as well as monitoring the QC of production. In addition, the drug development markets are served through a range of products which include SistemTOX™, SistemKB™ and SistemRNA™.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.